Use of defibrotide to treat adult patients with transplant-associated thrombotic microangiopathy

M E Martínez-Muñoz; R Forés; A Lario; G Bautista; J L Bueno; C de Miguel; B Navarro; A De Laiglesia; A Sánchez-Guerrero; J R Cabrera; R F Duarte

doi:10.1038/s41409-018-0256-8

Use of defibrotide to treat adult patients with transplant-associated thrombotic microangiopathy

Bone Marrow Transplant. 2019 Jan;54(1):142-145. doi: 10.1038/s41409-018-0256-8. Epub 2018 Jun 13.

Authors

M E Martínez-Muñoz^{1

2}, R Forés^{1

2}, A Lario¹, G Bautista^{1

2}, J L Bueno^{1

2}, C de Miguel^{1

2}, B Navarro^{1

2}, A De Laiglesia^{1

2}, A Sánchez-Guerrero^{2

3}, J R Cabrera^{1

2}, R F Duarte^{4

5}

Affiliations

¹ Department of Hematology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
² Biomedical Research Institute Puerta de Hierro Segovia de Arana, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
³ Hospital Pharmacy, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
⁴ Department of Hematology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain. [email protected].
⁵ Biomedical Research Institute Puerta de Hierro Segovia de Arana, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain. [email protected].

PMID: 29899573
DOI: 10.1038/s41409-018-0256-8

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Allografts
Female
Hematologic Neoplasms* / mortality
Hematologic Neoplasms* / therapy
Hematopoietic Stem Cell Transplantation*
Humans
Male
Middle Aged
Thrombotic Microangiopathies* / etiology
Thrombotic Microangiopathies* / mortality
Transplantation Conditioning*
Transplants*